ArticleEClinicalMedicine2024

Response to Campbell et al.'s comments on our study "Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study".

Alizée Bozonnat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.